Phase III HIV-1 vaccine trials require better rationale

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1423, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials

By Kebba Anthony   Imami Nesrina   Bugembe-Lule Daniel   Senkaali David   Kaleebu Pontiano   Grosskurth Heiner   Gotch Frances  

Pharmacogenomics, Vol. 8, Iss. 4, 2007-04 ,pp. : 409-414

Future Medicine

Access to resources Recommend Favorite

Justification for Thai phase III HIV vaccine trial

By  

Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Missing Data Imputation in Two Phase III Trials Treating HIV1 Infection

By Huson L. W.  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 1, 2007-01 ,pp. : 159-172

Taylor & Francis Ltd

Access to resources Recommend Favorite

Natalizumab doing well outside phase III trials

By  

Reactions Weekly, Vol. 1, Iss. 1275, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cancer vaccines entering Phase III clinical trials

By Durrant LG   Spendlove I  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite